BB-301: a silence and replace AAV-based vector for the treatment of oculopharyngeal muscular dystrophy
Oculopharyngeal muscular dystrophy (OPMD) is a rare autosomal dominant disease that results from an alanine expansion in the N-terminal domain of Poly-A Binding Protein Nuclear-1 (PABPN1). We have recently demonstrated that a two-vector gene therapy strategy significantly ameliorated the pathology i...
Saved in:
Main Authors: | Vanessa Strings-Ufombah (Author), Alberto Malerba (Author), Shih-Chu Kao (Author), Sonal Harbaran (Author), Fanny Roth (Author), Ornella Cappellari (Author), Ngoc Lu-Nguyen (Author), Keiko Takahashi (Author), Sophie Mukadam (Author), Georgina Kilfoil (Author), Claudia Kloth (Author), Petrus Roelvink (Author), George Dickson (Author), Capucine Trollet (Author), David Suhy (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD)
by: Pradeep Harish, et al.
Published: (2019) -
Different outcomes of endurance and resistance exercise in skeletal muscles of Oculopharyngeal muscular dystrophy
by: Alexis Boulinguiez, et al.
Published: (2024) -
RNA-Based Therapy Utilizing Oculopharyngeal Muscular Dystrophy Transcript Knockdown and Replacement
by: Aida Abu-Baker, et al.
Published: (2019) -
Engineered AAV2.7m8 Serotype Shows Significantly Higher Transduction Efficiency of ARPE-19 and HEK293 Cell Lines Compared to AAV5, AAV8 and AAV9 Serotypes
by: Dzerassa Gurtsieva, et al.
Published: (2024) -
Rapamycin immune tolerization enables gene transfer following subcutaneous delivery of AAV6 but not CD4-retargeted AAV6 vectors in AAV-seropositive rhesus macaques
by: K. Jerome, et al.
Published: (2019)